Lirafit

Lirafit 6mg Injection contains an active ingredient known as Liraglutide. This medication is classified under a category of mineral salts. It is utilized for the treatment of type 2 diabetes. Additionally, it helps in lowering the risk of significant cardiovascular events (heart disease) in adults diagnosed with type 2 diabetes. This treatment is recommended when dietary changes, physical activity, and other diabetes medications fail to adequately manage blood sugar levels. Prior to using this medication, inform your doctor if you have any allergies to it or its components.

It is not advisable for individuals with type 1 diabetes, diabetic ketoacidosis (a condition where the body generates excessive blood acid), liver disease, heart failure, gastrointestinal issues (such as inflammatory bowel disease), acute pancreatitis, or thyroid disorders. If you are considering pregnancy or suspect you might be pregnant while breastfeeding, consult your physician. Lirafit 6mg Injection may lead to hypoglycemia (low blood sugar), which can impair concentration. Therefore, it is recommended to refrain from driving or operating machinery if you experience symptoms of hypoglycemia.